Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-13430.07%
operating margin TTM
-14014.75%
revenue TTM
N/A
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | -0.52 |
| peg ratio | -0.05 |
| price to book ratio | 0.94 |
| price to sales ratio | 70.58 |
| enterprise value multiple | -0.56 |
| price fair value | 0.94 |
profitability ratios | |
|---|---|
| gross profit margin | -22.12% |
| operating profit margin | -14014.75% |
| pretax profit margin | -13430.07% |
| net profit margin | -13430.07% |
| return on assets | -122.3% |
| return on equity | -115.67% |
| return on capital employed | -159.08% |
liquidity ratios | |
|---|---|
| current ratio | 4.52 |
| quick ratio | 4.52 |
| cash ratio | 1.02 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 280.06 |
| days of payables outstanding | 2,858.19 |
| cash conversion cycle | -2,578.14 |
| receivables turnover | 1.30 |
| payables turnover | 0.13 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.17 |
| debt equity ratio | 0.25 |
| long term debt to capitalization | 0.10 |
| total debt to capitalization | 0.20 |
| interest coverage | -72.24 |
| cash flow to debt ratio | -6.52 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.98 |
| cash per share | 1.48 |
| operating cash flow per share | -1.97 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -6.52 |
| short term coverage ratios | -34.67 |
| capital expenditure coverage ratio | -333.83 |
Frequently Asked Questions
When was the last time ALX Oncology Holdings Inc. (NASDAQ:ALXO) reported earnings?
ALX Oncology Holdings Inc. (ALXO) published its most recent earnings results on 07-11-2025.
What is ALX Oncology Holdings Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. ALX Oncology Holdings Inc. (NASDAQ:ALXO)'s trailing twelve months ROE is -115.67%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. ALX Oncology Holdings Inc. (ALXO) currently has a ROA of -122.3%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ALXO's net profit margin stand at?
ALXO reported a profit margin of -13430.07% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ALXO's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 4.52 in the most recent quarter. The quick ratio stood at 4.52, with a Debt/Eq ratio of 0.25.